FDA finds ADHD drugs have no link to Cardiovascular problems

The US FDA has announced that a large, recently-completed study in children and young adults treated with medication for Attention-Deficit/Hyperactivity Disorder (ADHD) has not shown an association between use of certain ADHD medications and adverse cardiovascular events. These adverse cardiovascular events include stroke, heart attack (myocardial infarction or MI), and sudden cardiac death. The study was conducted with 1,200,438 children and young adults (aged 2-24 years) and only found 7 serious cardiovascular events in current users, suggesting no evidence of increased risk of serious cardiovascular effects among children and young people who use ADHD medications. The final study report has also been released. See: "ADHD Drugs and Serious Cardiovascular Events in Children and Young Adults" William Cooper et al. New England Journal of Medicine DOI: 10.1056/NEJMoa1110212